Vecuronium infusion dose requirements during fentanyl and halothane anesthesia in humans.

scientific article published in April 1985

Vecuronium infusion dose requirements during fentanyl and halothane anesthesia in humans. is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID2858991

P2093author name stringGencarelli PJ
Koot HW
Swen J
P433issue4
P407language of work or nameEnglishQ1860
P921main subjecthalothaneQ32921
fentanylQ407541
P1104number of pages4
P304page(s)411-414
P577publication date1985-04-01
P1433published inAnesthesia & AnalgesiaQ72225
P1476titleVecuronium infusion dose requirements during fentanyl and halothane anesthesia in humans.
P478volume64

Reverse relations

cites work (P2860)
Q51774956A simple method for monitoring muscular relaxation during continuous infusion of vecuronium.
Q38138137A simulation of neuromuscular function and heart rate during induction, maintenance, and reversal of neuromuscular blockade
Q51774150Continuous infusion of vecuronium in children.
Q51680932Continuous infusions of atracurium and vecuronium, compared with intermittent boluses of pancuronium: dose requirements and reversal
Q41199866Drug interactions with neuromuscular blockers
Q50046551Effect of low-dose infusion of prostaglandin E1 on vecuronium-induced neuromuscular blockade
Q41412538Neuromuscular transmission and its pharmacological blockade. Part 2: Pharmacology of neuromuscular blocking agents
Q39669506New intravenous anaesthetics and neuromuscular blocking drugs. A review of their properties and clinical use.

Search more.